Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 2012. The document serves as a notification of a transaction involving a Person Discharging Managerial Responsibility (PDMR) under the Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific equity transaction and does not contain financial performance data.
Material Changes
The filing details a change in the shareholding of Mrs. V. Whyte, a PDMR. She received an award of 13,070 Ordinary Shares under the GlaxoSmithKline 2009 Share Value Plan (SVP) on August 22, 2012. The award was calculated based on a share price of £14.425 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a regulatory notification of a director's share transaction.
Investor Verification Points
- Verify the total number of shares awarded to Mrs. V. Whyte (13,070 shares).
- Confirm the valuation price used for the award (£14.425 per share).
- Note the transaction date (August 22, 2012) and notification date (August 23, 2012).
- Understand that this filing does not reflect the company's broader financial performance for the period.